Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention
Authors:
Open Access
- 15 October 2018
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 50 (12) , 2193-2200
Abstract
Background Prostate cancer (PCa) is a common malignant human tumor and one of the main causes of cancer-related deaths in men. At present, prostate-specific antigen levels are widely used to diagnose PCa in the clinic, but they are not sufficient for an accurate early diagnosis or prognosis. Methods To identify potential molecular markers for PCa, we used real-time PCR to measure the expression levels of various microRNAs, including miR-1825, miR-484, miR-205, miR-141, and let-7b, in the serum of 72 PCa patients and 34 healthy controls. Results miR-1825, miR-484, miR-205, miR-141, and let-7b were shown to be highly specific for PCa, suggesting that they could be used as PCa tumor screening biomarkers. miR-205 may also be used as a biomarker for indicating bone metastasis in PCa patients, miR-1825 levels may help indicate tumor–node–metastasis classification, the evaluation of treatment effects, and determining prognosis, while let-7b levels may indicate potential tumor malignancy and the hormone resistance status and could be used as a basis to adjust individual treatments for the high-risk, early diagnosis of refractory PCa. Conclusion This study identified possible PCa tumor markers to more accurately predict the occurrence, progression, and prognosis of PCa, and which could be used in the development of tumor drug therapy.Keywords
Funding Information
- Qingdao Science and Technology Bureau (15-9-2-67-nsh)
This publication has 30 references indexed in Scilit:
- Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate CancerPLOS ONE, 2013
- Circulating microRNAs as potential new biomarkers for prostate cancerBritish Journal of Cancer, 2013
- Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancerProceedings of the National Academy of Sciences, 2012
- Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2PLOS ONE, 2012
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIMPLOS ONE, 2012
- Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathwayEndocrine-Related Cancer, 2012
- Regulation of microRNA expression and function by nuclear receptor signalingCell & Bioscience, 2011
- Detection of Cancer with Serum miRNAs on an Oligonucleotide MicroarrayPLOS ONE, 2009
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001